颈动脉血运重建内膜切除与支架试验(CREST)及美国医疗保险和医疗补助服务中心(CMS)颈动脉指南发布对高危患者颈动脉支架置入使用和结局的影响
该研究基于美国全国住院患者样本(NIS)2005至2011年数据,分析高危颈动脉狭窄患者中颈动脉支架置入(CAS)的使用趋势及结局。结果显示高危症状性患者CAS使用比例从18.6%增至24.4%(P < .001),但CAS术后院内死亡(OR 2.56)和卒中(OR 1.53)风险显著高于颈动脉内膜切除(CEA)。
要点
- 高危症状性患者CAS使用比例从18.6%升至24.4%,总体呈显著增加趋势
- CAS术后院内死亡风险(OR 2.56)和卒中风险(OR 1.53)显著高于CEA
- 2008至2010年CAS使用比值比每季度下降3.3%(OR 0.967,P = .002)
核心结论
- 2005至2011年间高危患者CAS使用显著增加,CAS独立增加围术期院内卒中风险,症状性高危患者中死亡风险亦增加。
研究设计与样本
- 基于美国全国住院患者样本(NIS)2005至2011年数据的回顾性队列研究,纳入Charlson合并症评分≥3.0的高危颈动脉血运重建患者。
- 共分析20079例CEA和3447例CAS,采用分段线性趋势logistic回归和多因素logistic回归比较不同时间段的CAS使用趋势及术后结局。
主要发现
- 高危症状性患者中CAS占颈动脉血运重建的20.5%,研究期间从18.6%显著增至24.4%(P < .001)。
- 2005至2008年CAS使用率初始增加,2008至2010年CAS使用比值比每季度下降3.3%(OR 0.967,95%CI 0.943-0.993,P = .002)。
- 2010年CREST发表后CAS使用较发表前继续显著增加。
- 总体高危样本中CAS患者院内死亡(OR 2.56,95%CI 1.17-5.62,P = .019)和术后院内卒中(OR 1.53,95%CI 1.09-3.68,P = .024)风险独立且显著高于CEA。
临床怎么用
- 高危颈动脉狭窄患者选择CAS时应充分权衡其较高的围术期卒中和死亡风险,尤其症状性患者。
- CMS指南和CREST发表与CAS使用趋势变化相关,临床决策需结合最新证据和患者个体风险。
局限性
- 研究为回顾性分析,仅反映2005至2011年数据,不能推断因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Since the 2004 approval by the United States Food and Drug Administration of carotid artery stenting (CAS), there have been two seminal publications about CAS reimbursement (Centers for Medicare and Medicaid Services guidelines; 2008) and clinical outcomes (Carotid Revascularization Endarterectomy versus Stent Trial [CREST]; 2010). We explored the association between these publications and national trends in CAS use among high-risk symptomatic patients. METHODS: The most recent congruent data sets of the Nationwide Inpatient Sample (NIS) were queried for patients undergoing carotid revascularization. The sample was limited to include only patients who were defined as "high-risk" if they had a Charlson Comorbidity Score of ≥3.0. Subgroup analyses were performed of high-risk patients with symptomatic carotid stenosis. Utilization proportions of CAS were calculated quarterly from 2005 to 2011 for NIS. Three time intervals related to Centers for Medicare and Medicaid Services guidelines and CREST publication were selected: 2005 to 2008, 2008 to 2010, and after 2010. Logistic regression with piecewise linear trend for time was used to estimate different trends in CAS use for the overall high-risk sample and for neurologically asymptomatic and symptomatic cases. Multivariate logistic regression was used to compare odds of postoperative mortality and stroke between these two procedures at different time intervals independent of confounding variables. RESULTS: During the study period, 20,079 carotid endarterectomies (CEAs) and 3447 CAS procedures were performed in high-risk patients in the NIS database. CAS utilization constituted 20.5% of carotid revascularization procedures among high-risk symptomatic patients, with a significant increase from 18.6% to 24.4% during the study period (P < .001). There was an initial increase during 2005 to 2008 in the rate of CAS compared with CEA, CAS utilization significantly decreased during 2008 to 2010 by a 3.3% decline in the odds ratio (OR) of CAS per quarter (OR, 0.967; 95% confidence interval [CI], 0.943-0.993; P = .002), and after CREST (after 2010), CAS utilization continued to increase significantly from the prepublication to the postpublication time interval. The odds of in-hospital mortality (OR, 2.56; 95% CI, 1.17-5.62; P = .019) and postoperative in-hospital stroke (OR, 1.53; 95% CI, 1.09-3.68; P = .024) were independently and significantly higher for CAS patients in the overall sample. CONCLUSIONS: The use of CAS for carotid revascularization in a high-risk cohort of patients has significantly increased from 2005 to 2011. Compared with CEA, CAS independently increased the odds of perioperative in-hospital stroke in all high-risk patients and of in-hospital mortality in symptomatic high-risk patients.
引用
- Salzler GG, Farber A, Rybin DV, et al. The association of Carotid Revascularization Endarterectomy versus Stent Trial (CREST) and Centers for Medicare and Medicaid Services Carotid Guideline Publication on utilization and outcomes of carotid stenting among "high-risk" patients. J Vasc Surg. 2017. PMID: 28502543. doi:10.1016/j.jvs.2017.02.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。